Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0000899243-18-030797

SVP, Chief Development Officer gave up 11,928 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Tubridy Karen L · SVP, Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-12-12 Shares withheld for taxes : show line 1 in the form −11,928 $8.94 $106,636 30,229 D
Loading xslF345X03/doc4.xml…